Trial Profile
A Prospective, Multicentre, Randomized, Open Label, Evaluator-Blind, Phase IV Study to Evaluate the Effect on Improvement of Left Ventricular Hypertrophy by the Control of Blood Pressure in Hypertension Patients With Aortic Valve Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Sep 2022
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Amlodipine/chlortalidone/losartan (Primary) ; Amlodipine/losartan (Primary) ; Losartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Hanmi Pharmaceutical
- 13 Sep 2022 Status changed from recruiting to completed.
- 18 Sep 2018 New trial record